Perturbation of platelet adhesion to endothelial cells by plasminogen activation in vitro.

Chen H¹, Wu YI¹, Hsieh YL, Shi GY, Jiang MJ, Chang WC, Chuang WJ, Kan WM, Tang MJ, Jen CJ.

¹Department of Physiology, National Cheng-Kung University, Tainan, Taiwan, ROC.

Abstract

To investigate whether the endothelium-platelet interactions may be altered by plasminogen activation, cultured human umbilical vein endothelial cells (ECs) were treated with tissue-type plasminogen activator (t-PA) in the presence of plasminogen, and platelet adhesion to ECs was subsequently measured by using a tapered flow chamber. Our results demonstrated that platelets adhered more readily to t-PA treated EC monolayer than to the control monolayer at all shear stress levels tested. This phenomenon was treatment time-dependent and dose-dependent, and it could be blocked by adding plasmin inhibitors, such as epsilon-amino caproic acid and aprotinin. Adherent platelets on t-PA treated EC monolayer underwent more severe shape change than those on the control monolayer. While the extracellular matrix directly treated with t-PA attracted less platelets than the control matrix did, platelet adhesion to the matrix that was produced by t-PA-treated ECs was unaltered. These data suggest that t-PA treatment on ECs compromised antiplatelet-adhesion capability on their apical surface without altering the reactivity of their extracellular matrix towards platelets.

Publication Types

• Research Support, Non-U.S. Gov't
• 
  

  MeSH Terms

• Blood Platelets/cytology*
• Cell Adhesion/drug effects
• Cell Adhesion/physiology
• Cells, Cultured
• Endothelium, Vascular/cytology*
• Humans
• Plasminogen/physiology*
• Plasminogen Activators/pharmacology*
• Tissue Plasminogen Activator/pharmacology*

Substances

• Plasminogen
• Plasminogen Activators
• Tissue Plasminogen Activator